BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1320752)

  • 21. Pituitary adenylate cyclase-activating polypeptide (PACAP) and PACAP-receptor type 1 expression in rat and human placenta.
    Scaldaferri ML; Modesti A; Palumbo C; Ulisse S; Fabbri A; Piccione E; Frajese G; Moretti C
    Endocrinology; 2000 Mar; 141(3):1158-67. PubMed ID: 10698193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and expression of a complementary DNA encoding the bovine receptor for pituitary adenylate cyclase-activating polypeptide (PACAP).
    Miyamoto Y; Habata Y; Ohtaki T; Masuda Y; Ogi K; Onda H; Fujino M
    Biochim Biophys Acta; 1994 Aug; 1218(3):297-307. PubMed ID: 8049255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The novel VIP-like hypothalamic polypeptide PACAP interacts with high affinity receptors in the human neuroblastoma cell line NB-OK.
    Cauvin A; Buscail L; Gourlet P; De Neef P; Gossen D; Arimura A; Miyata A; Coy DH; Robberecht P; Christophe J
    Peptides; 1990; 11(4):773-7. PubMed ID: 2172943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophages.
    Pozo D; Delgado M; Martinez C; Gomariz RP; Guerrero JM; Calvo JR
    Biochim Biophys Acta; 1997 Dec; 1359(3):250-62. PubMed ID: 9434131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections.
    Masuo Y; Ohtaki T; Masuda Y; Tsuda M; Fujino M
    Brain Res; 1992 Mar; 575(1):113-23. PubMed ID: 1324082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pituitary adenylate cyclase-activating polypeptide].
    Gonzalez BJ; Basille M; Vaudry D; Fournier A; Vaudry H
    Ann Endocrinol (Paris); 1998 Dec; 59(5):364-405. PubMed ID: 9949891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural requirements for the binding of the pituitary adenylate-cyclase-activating peptide to receptors and adenylate-cyclase activation in pancreatic and neuronal membranes.
    Gourlet P; Woussen-Colle MC; Robberecht P; de Neef P; Cauvin A; Vandermeers-Piret MC; Vandermeers A; Christophe J
    Eur J Biochem; 1991 Jan; 195(2):535-41. PubMed ID: 1997328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PACAP and VIP receptors in rat liver membranes.
    Robberecht P; Gourlet P; Cauvin A; Buscail L; De Neef P; Arimura A; Christophe J
    Am J Physiol; 1991 Jan; 260(1 Pt 1):G97-102. PubMed ID: 1846275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addition of the (28-38) peptide sequence of PACAP to the VIP sequence modifies peptide selectivity and efficacy.
    Gourlet P; Vandermeers A; Vandermeers-Piret MC; De Neef P; Robberecht P
    Int J Pept Protein Res; 1996 Oct; 48(4):391-6. PubMed ID: 8919060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PACAP and VIP stimulate enzyme secretion in rat pancreatic acini via interaction with VIP/PACAP-2 receptors: additive augmentation of CCK/carbachol-induced enzyme release.
    Schmidt WE; Seebeck J; Höcker M; Schwarzhoff R; Schäfer H; Fornefeld H; Morys-Wortmann C; Fölsch UR; Creutzfeldt W
    Pancreas; 1993 Jul; 8(4):476-87. PubMed ID: 8103217
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The stimulatory effects and binding characteristics of PACAP27 in rat dispersed pancreatic acini.
    Kashimura J; Shimosegawa T; Iguchi K; Mochizuki T; Yanaihara N; Koizumi M; Toyota T
    Tohoku J Exp Med; 1993 Nov; 171(3):243-54. PubMed ID: 7512757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Properties of the pituitary adenylate cyclase-activating polypeptide I and II receptors, vasoactive intestinal peptide1, and chimeric amino-terminal pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal peptide1 receptors: evidence for multiple receptor states.
    Van Rampelbergh J; Gourlet P; De Neef P; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1996 Dec; 50(6):1596-604. PubMed ID: 8967982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular cloning and functional expression of rat cDNAs encoding the receptor for pituitary adenylate cyclase activating polypeptide (PACAP).
    Hosoya M; Onda H; Ogi K; Masuda Y; Miyamoto Y; Ohtaki T; Okazaki H; Arimura A; Fujino M
    Biochem Biophys Res Commun; 1993 Jul; 194(1):133-43. PubMed ID: 7687425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptors for pituitary adenylate cyclase-activating peptide in human liver.
    Guijarro LG; Rodriguez-Henche N; García-López E; Noguerales F; Dapena MA; Juarranz MG; Prieto JC
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2451-7. PubMed ID: 7629241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Localization and characterization of PACAP receptors in the rat cerebellum during development: evidence for a stimulatory effect of PACAP on immature cerebellar granule cells.
    Basille M; Gonzalez BJ; Leroux P; Jeandel L; Fournier A; Vaudry H
    Neuroscience; 1993 Nov; 57(2):329-38. PubMed ID: 8115042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of lipophilic VIP derivatives with recombinant VIP1/PACAP and VIP2/PACAP receptors.
    Gourlet P; Rathé J; De Neef P; Cnudde J; Vandermeers-Piret MC; Waelbroeck M; Robberecht P
    Eur J Pharmacol; 1998 Jul; 354(1):105-11. PubMed ID: 9726637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PAC1 receptors in chick cerebral cortex: characterization by binding of pituitary adenylate cyclase-activating polypeptide, [125I]-PACAP27.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Neurosci Lett; 2003 Feb; 338(2):155-8. PubMed ID: 12566176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor.
    Wong AO; Leung MY; Shea WL; Tse LY; Chang JP; Chow BK
    Endocrinology; 1998 Aug; 139(8):3465-79. PubMed ID: 9681497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.